Nonallergic rhinitis and lower airway disease

In the past years, several investigators have demonstrated the existence of local nasal responses in some patients with typical allergic rhinitis symptoms but without atopy and have defined a new phenotype called local allergic rhinitis (LAR) or ‘entopy’. In a percentage of LAR subjects, the upper a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Allergy (Copenhagen) 2017-01, Vol.72 (1), p.24-34
Hauptverfasser: Rondón, C., Bogas, G., Barrionuevo, E., Blanca, M., Torres, M. J., Campo, P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 34
container_issue 1
container_start_page 24
container_title Allergy (Copenhagen)
container_volume 72
creator Rondón, C.
Bogas, G.
Barrionuevo, E.
Blanca, M.
Torres, M. J.
Campo, P.
description In the past years, several investigators have demonstrated the existence of local nasal responses in some patients with typical allergic rhinitis symptoms but without atopy and have defined a new phenotype called local allergic rhinitis (LAR) or ‘entopy’. In a percentage of LAR subjects, the upper airway disease is also associated with lower airway symptoms. After the description of this phenotype, the differential diagnosis between LAR and nonallergic rhinitis (NAR) has become a challenge for the clinician. To correctly identify LAR patients is of high importance for treatment and management of these patients, and for an appropriate inclusion of patients in clinical trials and genetics studies. The treatment of LAR patients, in contrast with NAR, is oriented to allergen avoidance and specific treatment. Allergen immunotherapy, the aetiological treatment for allergic respiratory diseases, has demonstrated to be an effective and safe treatment in LAR, increasing immunological tolerance, and reducing the clinical symptoms and the use of medication. In this article, the important and novel aspects of LAR in terms of mechanisms, diagnosis and treatment will be discussed. Also, the involvement of the lower airway and the potential role of IgE in the bronchial disease will be also reviewed.
doi_str_mv 10.1111/all.12988
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1855072443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826723487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4218-4c14c0e6f2f582fd1b99f41f7017607b8483ce0d6ea4ea3a6cda446cd2279bae3</originalsourceid><addsrcrecordid>eNqN0MtKw0AUBuBBFFurC19AAm50kXZumctSijcIutH1MElOdEqa1JmG0rd3aqoLQfAs5my--eH8CJ0TPCVxZrZppoRqpQ7QmDCtUq11dojGmOAs5RlTI3QSwgJjLKnGx2hEJWcaUz5G6VPXxu_g31yZ-HfXurULiW2rpOk24BPr_MZuk8oFsAFO0VFtmwBn-z1Br3e3L_OHNH--f5zf5GnJKVEpLwkvMYia1pmidUUKrWtOaomJFFgWiitWAq4EWA6WWVFWlvP4Uip1YYFN0NWQu_LdRw9hbZYulNA0toWuD4aoLIu3cM7-QamQlHElI738RRdd7-P5O8UVxkILEdX1oErfheChNivvltZvDcFmV7eJfZmvuqO92Cf2xRKqH_ndbwSzAWxcA9u_k8xNng-Rn35whxY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1848006966</pqid></control><display><type>article</type><title>Nonallergic rhinitis and lower airway disease</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Rondón, C. ; Bogas, G. ; Barrionuevo, E. ; Blanca, M. ; Torres, M. J. ; Campo, P.</creator><creatorcontrib>Rondón, C. ; Bogas, G. ; Barrionuevo, E. ; Blanca, M. ; Torres, M. J. ; Campo, P.</creatorcontrib><description>In the past years, several investigators have demonstrated the existence of local nasal responses in some patients with typical allergic rhinitis symptoms but without atopy and have defined a new phenotype called local allergic rhinitis (LAR) or ‘entopy’. In a percentage of LAR subjects, the upper airway disease is also associated with lower airway symptoms. After the description of this phenotype, the differential diagnosis between LAR and nonallergic rhinitis (NAR) has become a challenge for the clinician. To correctly identify LAR patients is of high importance for treatment and management of these patients, and for an appropriate inclusion of patients in clinical trials and genetics studies. The treatment of LAR patients, in contrast with NAR, is oriented to allergen avoidance and specific treatment. Allergen immunotherapy, the aetiological treatment for allergic respiratory diseases, has demonstrated to be an effective and safe treatment in LAR, increasing immunological tolerance, and reducing the clinical symptoms and the use of medication. In this article, the important and novel aspects of LAR in terms of mechanisms, diagnosis and treatment will be discussed. Also, the involvement of the lower airway and the potential role of IgE in the bronchial disease will be also reviewed.</description><identifier>ISSN: 0105-4538</identifier><identifier>EISSN: 1398-9995</identifier><identifier>DOI: 10.1111/all.12988</identifier><identifier>PMID: 27439024</identifier><language>eng</language><publisher>Denmark: Blackwell Publishing Ltd</publisher><subject>allergen immunotherapy ; Allergies ; asthma ; Asthma - diagnosis ; Asthma - etiology ; Basophils - immunology ; Basophils - metabolism ; Biomarkers ; Cell Adhesion Molecules - metabolism ; Diagnosis, Differential ; Humans ; Immunoglobulin E - immunology ; local allergic rhinitis ; local IgE ; Medical diagnosis ; Medical treatment ; Nasal Mucosa - immunology ; Nasal Mucosa - metabolism ; nonallergic rhinitis ; Nose ; Phenotype ; Respiratory diseases ; Respiratory Tract Diseases - diagnosis ; Respiratory Tract Diseases - etiology ; Respiratory Tract Diseases - metabolism ; Respiratory Tract Diseases - therapy ; Rhinitis - diagnosis ; Rhinitis - etiology ; Rhinitis - metabolism ; Rhinitis - therapy</subject><ispartof>Allergy (Copenhagen), 2017-01, Vol.72 (1), p.24-34</ispartof><rights>2016 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2016 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2017 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4218-4c14c0e6f2f582fd1b99f41f7017607b8483ce0d6ea4ea3a6cda446cd2279bae3</citedby><cites>FETCH-LOGICAL-c4218-4c14c0e6f2f582fd1b99f41f7017607b8483ce0d6ea4ea3a6cda446cd2279bae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fall.12988$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fall.12988$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27439024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rondón, C.</creatorcontrib><creatorcontrib>Bogas, G.</creatorcontrib><creatorcontrib>Barrionuevo, E.</creatorcontrib><creatorcontrib>Blanca, M.</creatorcontrib><creatorcontrib>Torres, M. J.</creatorcontrib><creatorcontrib>Campo, P.</creatorcontrib><title>Nonallergic rhinitis and lower airway disease</title><title>Allergy (Copenhagen)</title><addtitle>Allergy</addtitle><description>In the past years, several investigators have demonstrated the existence of local nasal responses in some patients with typical allergic rhinitis symptoms but without atopy and have defined a new phenotype called local allergic rhinitis (LAR) or ‘entopy’. In a percentage of LAR subjects, the upper airway disease is also associated with lower airway symptoms. After the description of this phenotype, the differential diagnosis between LAR and nonallergic rhinitis (NAR) has become a challenge for the clinician. To correctly identify LAR patients is of high importance for treatment and management of these patients, and for an appropriate inclusion of patients in clinical trials and genetics studies. The treatment of LAR patients, in contrast with NAR, is oriented to allergen avoidance and specific treatment. Allergen immunotherapy, the aetiological treatment for allergic respiratory diseases, has demonstrated to be an effective and safe treatment in LAR, increasing immunological tolerance, and reducing the clinical symptoms and the use of medication. In this article, the important and novel aspects of LAR in terms of mechanisms, diagnosis and treatment will be discussed. Also, the involvement of the lower airway and the potential role of IgE in the bronchial disease will be also reviewed.</description><subject>allergen immunotherapy</subject><subject>Allergies</subject><subject>asthma</subject><subject>Asthma - diagnosis</subject><subject>Asthma - etiology</subject><subject>Basophils - immunology</subject><subject>Basophils - metabolism</subject><subject>Biomarkers</subject><subject>Cell Adhesion Molecules - metabolism</subject><subject>Diagnosis, Differential</subject><subject>Humans</subject><subject>Immunoglobulin E - immunology</subject><subject>local allergic rhinitis</subject><subject>local IgE</subject><subject>Medical diagnosis</subject><subject>Medical treatment</subject><subject>Nasal Mucosa - immunology</subject><subject>Nasal Mucosa - metabolism</subject><subject>nonallergic rhinitis</subject><subject>Nose</subject><subject>Phenotype</subject><subject>Respiratory diseases</subject><subject>Respiratory Tract Diseases - diagnosis</subject><subject>Respiratory Tract Diseases - etiology</subject><subject>Respiratory Tract Diseases - metabolism</subject><subject>Respiratory Tract Diseases - therapy</subject><subject>Rhinitis - diagnosis</subject><subject>Rhinitis - etiology</subject><subject>Rhinitis - metabolism</subject><subject>Rhinitis - therapy</subject><issn>0105-4538</issn><issn>1398-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0MtKw0AUBuBBFFurC19AAm50kXZumctSijcIutH1MElOdEqa1JmG0rd3aqoLQfAs5my--eH8CJ0TPCVxZrZppoRqpQ7QmDCtUq11dojGmOAs5RlTI3QSwgJjLKnGx2hEJWcaUz5G6VPXxu_g31yZ-HfXurULiW2rpOk24BPr_MZuk8oFsAFO0VFtmwBn-z1Br3e3L_OHNH--f5zf5GnJKVEpLwkvMYia1pmidUUKrWtOaomJFFgWiitWAq4EWA6WWVFWlvP4Uip1YYFN0NWQu_LdRw9hbZYulNA0toWuD4aoLIu3cM7-QamQlHElI738RRdd7-P5O8UVxkILEdX1oErfheChNivvltZvDcFmV7eJfZmvuqO92Cf2xRKqH_ndbwSzAWxcA9u_k8xNng-Rn35whxY</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Rondón, C.</creator><creator>Bogas, G.</creator><creator>Barrionuevo, E.</creator><creator>Blanca, M.</creator><creator>Torres, M. J.</creator><creator>Campo, P.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201701</creationdate><title>Nonallergic rhinitis and lower airway disease</title><author>Rondón, C. ; Bogas, G. ; Barrionuevo, E. ; Blanca, M. ; Torres, M. J. ; Campo, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4218-4c14c0e6f2f582fd1b99f41f7017607b8483ce0d6ea4ea3a6cda446cd2279bae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>allergen immunotherapy</topic><topic>Allergies</topic><topic>asthma</topic><topic>Asthma - diagnosis</topic><topic>Asthma - etiology</topic><topic>Basophils - immunology</topic><topic>Basophils - metabolism</topic><topic>Biomarkers</topic><topic>Cell Adhesion Molecules - metabolism</topic><topic>Diagnosis, Differential</topic><topic>Humans</topic><topic>Immunoglobulin E - immunology</topic><topic>local allergic rhinitis</topic><topic>local IgE</topic><topic>Medical diagnosis</topic><topic>Medical treatment</topic><topic>Nasal Mucosa - immunology</topic><topic>Nasal Mucosa - metabolism</topic><topic>nonallergic rhinitis</topic><topic>Nose</topic><topic>Phenotype</topic><topic>Respiratory diseases</topic><topic>Respiratory Tract Diseases - diagnosis</topic><topic>Respiratory Tract Diseases - etiology</topic><topic>Respiratory Tract Diseases - metabolism</topic><topic>Respiratory Tract Diseases - therapy</topic><topic>Rhinitis - diagnosis</topic><topic>Rhinitis - etiology</topic><topic>Rhinitis - metabolism</topic><topic>Rhinitis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rondón, C.</creatorcontrib><creatorcontrib>Bogas, G.</creatorcontrib><creatorcontrib>Barrionuevo, E.</creatorcontrib><creatorcontrib>Blanca, M.</creatorcontrib><creatorcontrib>Torres, M. J.</creatorcontrib><creatorcontrib>Campo, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Allergy (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rondón, C.</au><au>Bogas, G.</au><au>Barrionuevo, E.</au><au>Blanca, M.</au><au>Torres, M. J.</au><au>Campo, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonallergic rhinitis and lower airway disease</atitle><jtitle>Allergy (Copenhagen)</jtitle><addtitle>Allergy</addtitle><date>2017-01</date><risdate>2017</risdate><volume>72</volume><issue>1</issue><spage>24</spage><epage>34</epage><pages>24-34</pages><issn>0105-4538</issn><eissn>1398-9995</eissn><abstract>In the past years, several investigators have demonstrated the existence of local nasal responses in some patients with typical allergic rhinitis symptoms but without atopy and have defined a new phenotype called local allergic rhinitis (LAR) or ‘entopy’. In a percentage of LAR subjects, the upper airway disease is also associated with lower airway symptoms. After the description of this phenotype, the differential diagnosis between LAR and nonallergic rhinitis (NAR) has become a challenge for the clinician. To correctly identify LAR patients is of high importance for treatment and management of these patients, and for an appropriate inclusion of patients in clinical trials and genetics studies. The treatment of LAR patients, in contrast with NAR, is oriented to allergen avoidance and specific treatment. Allergen immunotherapy, the aetiological treatment for allergic respiratory diseases, has demonstrated to be an effective and safe treatment in LAR, increasing immunological tolerance, and reducing the clinical symptoms and the use of medication. In this article, the important and novel aspects of LAR in terms of mechanisms, diagnosis and treatment will be discussed. Also, the involvement of the lower airway and the potential role of IgE in the bronchial disease will be also reviewed.</abstract><cop>Denmark</cop><pub>Blackwell Publishing Ltd</pub><pmid>27439024</pmid><doi>10.1111/all.12988</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0105-4538
ispartof Allergy (Copenhagen), 2017-01, Vol.72 (1), p.24-34
issn 0105-4538
1398-9995
language eng
recordid cdi_proquest_miscellaneous_1855072443
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects allergen immunotherapy
Allergies
asthma
Asthma - diagnosis
Asthma - etiology
Basophils - immunology
Basophils - metabolism
Biomarkers
Cell Adhesion Molecules - metabolism
Diagnosis, Differential
Humans
Immunoglobulin E - immunology
local allergic rhinitis
local IgE
Medical diagnosis
Medical treatment
Nasal Mucosa - immunology
Nasal Mucosa - metabolism
nonallergic rhinitis
Nose
Phenotype
Respiratory diseases
Respiratory Tract Diseases - diagnosis
Respiratory Tract Diseases - etiology
Respiratory Tract Diseases - metabolism
Respiratory Tract Diseases - therapy
Rhinitis - diagnosis
Rhinitis - etiology
Rhinitis - metabolism
Rhinitis - therapy
title Nonallergic rhinitis and lower airway disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T09%3A07%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonallergic%20rhinitis%20and%20lower%20airway%20disease&rft.jtitle=Allergy%20(Copenhagen)&rft.au=Rond%C3%B3n,%20C.&rft.date=2017-01&rft.volume=72&rft.issue=1&rft.spage=24&rft.epage=34&rft.pages=24-34&rft.issn=0105-4538&rft.eissn=1398-9995&rft_id=info:doi/10.1111/all.12988&rft_dat=%3Cproquest_cross%3E1826723487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1848006966&rft_id=info:pmid/27439024&rfr_iscdi=true